IgY Immune Technologies & Life Sciences
Thunder Bay
About IgY Immune Technologies & Life Sciences
IGY Immune Technologies & Life Sciences Inc. engages in the extraction of polyclonal antibodies for nutraceutical and pharmaceutical applications for human and animal consumption. Its antibodies are derived from chicken eggs. The company’s products are used in medicines, functional foods, agriculture/feeds, and cosmeceuticals. IGY Immune Technologies & Life Sciences Inc. was founded in 2009 and is based in Thunder Bay, Canada.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $65.1K
- Funding stage: Seed
- Last round: Seed (Feb 2012)
- Website: igylifesciences.com
- Phone: 807-343-6013
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/igy-immune-technologies-life-sciences-2736873 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.